In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.
This report contains market size and forecasts of In-Vitro Toxicity Testing in Global, including the following market information:
Global In-Vitro Toxicity Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global In-Vitro Toxicity Testing market was valued at 10180 million in 2021 and is projected to reach US$ 17010 million by 2028, at a CAGR of 7.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cell Culture Technologies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of In-Vitro Toxicity Testing include Thermo Fisher Scientific, Covance, Bio-Rad Laboratories, GE Healthcare, Eurofins Scientific, Merck KGaA, Charles River Laboratories, Catalent and Cyprotex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In-Vitro Toxicity Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In-Vitro Toxicity Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global In-Vitro Toxicity Testing Market Segment Percentages, by Type, 2021 (%)
Cell Culture Technologies
High-throughput Technologies
Toxicogenomics
Global In-Vitro Toxicity Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global In-Vitro Toxicity Testing Market Segment Percentages, by Application, 2021 (%)
Pharmaceuticals & Biopharmaceuticals
Cosmetic & Household Products
Food
Chemicals
Global In-Vitro Toxicity Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global In-Vitro Toxicity Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies In-Vitro Toxicity Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies In-Vitro Toxicity Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Covance
Bio-Rad Laboratories
GE Healthcare
Eurofins Scientific
Merck KGaA
Charles River Laboratories
Catalent
Cyprotex
QIAGEN
Promega
Gentronix
BioIVT
MB Research Laboratories